The 5-HT2 Receptor Profiles of Antipsychotics in the Pathogenesis of Obsessive-Compulsive Symptoms in Schizophrenia
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Atypical antipsychotics have been reported to induce or exacerbate obsessive-compulsive symptoms (OCS) in patients with schizophrenia. We report the development of de novo obsession induced by sequential treatment with risperidone, aripiprazole, and ziprasidone, which have an antagonist effect on serotonin 5-HT(2A) receptors in a patient with schizophrenia. The obsession was repeatedly improved after switching the atypical antipsychotics to amisulpride, a selective D(2) and D(3) receptor antagonist. To our knowledge, this is the first report about ziprasidone-induced OCS in a patient with schizophrenia. In conclusion, this case supports the hypothesis that the antagonist effect on 5-HT(2) receptors may be related to atypical antipsychotic-induced OCS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder
Saxena, S., & Rauch, S. L. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70181-7 · Cited by 840
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635 · cited 4×
“There is sufficient evidence demonstrating the efficacy of haloperidol in treatmentrefractory OCD.(4) In a comparative study between risperidone and haloperidol on refractory OCD, haloperidol demonstrated a stronger and significant reduction in the total Yale-Brown Obsessive Compulsive Scale (YBOCS) score than a place…”
BackgroundInfluentialImpact of Substance Use Disorder on ADHD and Its Treatment
Wilens, T. E., & Upadhyaya, H. P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0807e20 · Cited by 188
Stahl, S. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1101 · Cited by 143 · cited 1×
“Aripiprazole is classified as a dopamine partial agonist, whose mechanism is somewhat different from that of other AAPs that are serotonin-dopamine antagonists.(9) However, aripiprazole has potent 5-HT2A antagonism similar to other AAPs, which is thought to be related to the emergence of OCS.”
BackgroundLi, X., May, R. S., Tolbert, L. C., Jackson, W. T., Flournoy, J. M., & Baxter, L. R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0610 · Cited by 110 · cited 1×
“In a comparative study between risperidone and haloperidol on refractory OCD, haloperidol demonstrated a stronger and significant reduction in the total Yale-Brown Obsessive Compulsive Scale (YBOCS) score than a placebo, whereas risperidone, a serotonin-dopamine antagonist, did not significantly improve the total YBOC…”
Result
Cited by
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Serotonin Receptors – From Molecular Biology to Clinical Applications
PYTLIAK, M., VARGOVÁ, V., MECHÍROVÁ, V., & FELŠÖCI, M. (2011) · Physiological Research · doi:10.33549/physiolres.931903 · Cited by 318
Pharmacotherapy of obsessive–compulsive disorder: evidence-based treatment and beyond
Fineberg, N. A., Reghunandanan, S., Brown, A., & Pampaloni, I. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412461958 · Cited by 122
“Some authors report treatmentemergent obsessions during the treatment of schizophrenia with second-generation antipsychotics (Kim et al., 2009).”
BackgroundFonseka, T. M., Richter, M. A., & Müller, D. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0510-8 · Cited by 93
Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
Ettrup, A., Palner, M., Gillings, N., Santini, M. A., Hansen, M., Kornum, B. R., Rasmussen, L. K., Någren, K., Madsen, J., Begtrup, M., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.074021 · Cited by 50
Metadata
- Authors
- Kim, S.-W., Shin, I.-S., Kim, J.-M., Youn, T., Yang, S.-J., Hwang, M. Y., & Yoon, J.-S.
- Venue
- Clinical Neuropharmacology
- Published
- 2009-07
- Volume
- 32
- Issue
- 4
- Pages
- 224-226
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W1972684357
- Cited by
- 36
- References
- 5
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 5-HT2 Receptor Profiles of Antipsychotics in the Pathogenesis of Obsessive-Compulsive Symptoms in Schizophrenia. https://app.cochat.ai/papers/10.1097/wnf.0b013e318184fafd
- The paper
- Kim, S.-W., Shin, I.-S., Kim, J.-M., Youn, T., Yang, S.-J., Hwang, M. Y., & Yoon, J.-S. (2009). The 5-HT2 Receptor Profiles of Antipsychotics in the Pathogenesis of Obsessive-Compulsive Symptoms in Schizophrenia. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0b013e318184fafd
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.